|
1
|
Hardegger LA, Beney P, Bixel D, Fleury C, Gao F, Perrenoud AGG, Gu X, Haber J, Hong T, Humair R, Kaegi A, Kibiger M, Kleinbeck F, Luu VT, Padeste L, Rampf FA, Ruch T, Schlama T, Sidler E, Udvarhelyi A, Wietfeld B, Yang Y. Toward a Scalable Synthesis and Process for EMA401, Part III: Using an Engineered Phenylalanine Ammonia Lyase Enzyme to Synthesize a Non-natural Phenylalanine Derivative. Org Process Res Dev 2020. [DOI: 10.1021/acs.oprd.0c00217] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Leo A. Hardegger
- Chemical and Analytical Development, Novartis Pharma AG, 4002 Basel, Switzerland
| | - Pascal Beney
- Chemical and Analytical Development, Novartis Pharma AG, 4002 Basel, Switzerland
| | - Dominique Bixel
- Chemical and Analytical Development, Novartis Pharma AG, 4002 Basel, Switzerland
| | - Christian Fleury
- Chemical and Analytical Development, Novartis Pharma AG, 4002 Basel, Switzerland
| | - Feng Gao
- Suzhou Novartis Technical Development Co., Ltd., Changshu 215537, China
| | | | - Xingxian Gu
- Suzhou Novartis Technical Development Co., Ltd., Changshu 215537, China
| | - Julien Haber
- Chemical and Analytical Development, Novartis Pharma AG, 4002 Basel, Switzerland
| | - Tao Hong
- Suzhou Novartis Technical Development Co., Ltd., Changshu 215537, China
| | - Roger Humair
- Chemical and Analytical Development, Novartis Pharma AG, 4002 Basel, Switzerland
| | - Andreas Kaegi
- Chemical and Analytical Development, Novartis Pharma AG, 4002 Basel, Switzerland
| | - Michael Kibiger
- Chemical and Analytical Development, Novartis Pharma AG, 4002 Basel, Switzerland
| | - Florian Kleinbeck
- Chemical and Analytical Development, Novartis Pharma AG, 4002 Basel, Switzerland
| | - Van Tong Luu
- Chemical and Analytical Development, Novartis Pharma AG, 4002 Basel, Switzerland
| | - Lukas Padeste
- Chemical and Analytical Development, Novartis Pharma AG, 4002 Basel, Switzerland
| | - Florian A. Rampf
- Chemical and Analytical Development, Novartis Pharma AG, 4002 Basel, Switzerland
| | - Thomas Ruch
- Chemical and Analytical Development, Novartis Pharma AG, 4002 Basel, Switzerland
| | - Thierry Schlama
- Chemical and Analytical Development, Novartis Pharma AG, 4002 Basel, Switzerland
| | - Eric Sidler
- Chemical and Analytical Development, Novartis Pharma AG, 4002 Basel, Switzerland
| | - Anikó Udvarhelyi
- Pharmaceutical and Analytical Development, Novartis Pharma AG, 4002 Basel, Switzerland
| | - Bernhard Wietfeld
- Chemical and Analytical Development, Novartis Pharma AG, 4002 Basel, Switzerland
| | - Yao Yang
- Suzhou Novartis Technical Development Co., Ltd., Changshu 215537, China
| |
Collapse
|
|
2
|
Xue YP, Cao CH, Zheng YG. Enzymatic asymmetric synthesis of chiral amino acids. Chem Soc Rev 2018; 47:1516-1561. [DOI: 10.1039/c7cs00253j] [Citation(s) in RCA: 190] [Impact Index Per Article: 31.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
This review summarizes the progress achieved in the enzymatic asymmetric synthesis of chiral amino acids from prochiral substrates.
Collapse
Affiliation(s)
- Ya-Ping Xue
- Key Laboratory of Bioorganic Synthesis of Zhejiang Province
- College of Biotechnology and Bioengineering
- Zhejiang University of Technology
- Hangzhou 310014
- China
| | - Cheng-Hao Cao
- Key Laboratory of Bioorganic Synthesis of Zhejiang Province
- College of Biotechnology and Bioengineering
- Zhejiang University of Technology
- Hangzhou 310014
- China
| | - Yu-Guo Zheng
- Key Laboratory of Bioorganic Synthesis of Zhejiang Province
- College of Biotechnology and Bioengineering
- Zhejiang University of Technology
- Hangzhou 310014
- China
| |
Collapse
|
|
3
|
Poppe L, Paizs C, Kovács K, Irimie FD, Vértessy B. Preparation of unnatural amino acids with ammonia-lyases and 2,3-aminomutases. Methods Mol Biol 2012; 794:3-19. [PMID: 21956553 DOI: 10.1007/978-1-61779-331-8_1] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Ammonia-lyases catalyze a wide range of processes leading to α,β-unsaturated compounds by elimination of ammonia. In this chapter, ammonia-lyases are reviewed with major emphasis on their synthetic applications in stereoselective preparation of unnatural amino acids. Besides the synthesis of various unnatural α-amino acids with the aid of phenylalanine ammonia-lyases (PALs) utilizing the 3,5-dihydro-5-methylidene-4H-imidazol-4-one (MIO) prosthetic groups, the biotransformations leading to various unnatural β-amino acids with phenylalanine 2,3-aminomutases using the same catalytic MIO prosthetic group are discussed. Cloning, production, purification, and biotransformation protocols for PAL are described in detail.
Collapse
Affiliation(s)
- László Poppe
- Department of Organic Chemistry and Technology, Budapest University of Technology and Economics, Budapest, Hungary.
| | | | | | | | | |
Collapse
|